{{Rsnum
|rsid=2345039
|Chromosome=4
|Orientation=minus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=LPHN3
|position=61899312
|Gene_s=LPHN3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 44.6 | 44.6 | 10.8
| HCB | 37.8 | 48.9 | 13.3
| JPT | 29.5 | 56.8 | 13.6
| YRI | 36.5 | 46.0 | 17.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 37.8 | 48.9 | 13.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=25229170
|Title=Association of SNAP-25, SLC6A2, and LPHN3 With OROS Methylphenidate Treatment Response in Attention-Deficit/Hyperactivity Disorder
}}